(Total Views: 519)
Posted On: 10/13/2020 9:03:18 AM
Post# of 155592
Respert24, good points. For me, I gain optimism from the m/m trail. In this double blind trial, the data shows LL helped the moderate patients and produced a statistically significant reduction in SAEs. It seems logical and better than even odds, LL will also benefit the S/C population.

